Clinical trials
Infections clinical trials
Below are recruiting infections clinical trials, each written for real people, not researchers. We’re tracking 1,767 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07440485Recruiting
Aspergillus infection study for hematology patients
This study looks at Aspergillus infections in people admitted to the hematology ward. It aims to understand how common these infections are and how they affect patients.
Pavia, PaviaAges 18 years+ - NCT07473089Recruiting
Swiss study on joint replacement revision for infection
This study looks at people who need a second (revision) surgery on a large joint replacement like a hip, knee, shoulder, ankle, or elbow because of a suspected or confirmed infection. The goal is to learn more about these infections and improve care.
AarauAges 18 years+ - NCT07487623Recruiting
Nutritional supplement for liver protection in hepatitis C
This trial tests whether a special nutritional supplement can protect the liver in people with chronic hepatitis C. If you have mild to moderate liver damage and meet the criteria, you may be able to join.
Guadalajara, JaliscoAges 18–69 - NCT07489274RecruitingPhase 4
Hyperbaric oxygen for severe skin infections
This trial tests whether adding hyperbaric oxygen therapy to standard care helps adults with a serious soft-tissue infection. It could improve healing and reduce complications.
Antwerp, EdegemAges 18 years+ - NCT07519330RecruitingPhase 2
Testing HH-006 treatment for chronic hepatitis B
This study tests a new drug called HH-006 to see if it can help treat chronic hepatitis B infection. Participants will be grouped by their infection level, and the study checks whether the drug is safe and works to reduce the hepatitis B virus.
Chongqing, Chongqing MunicipalityAges 18–45 - NCT07523646RecruitingPhase 4
Blood Boost for Patients With Heart Valve Infections
This study tests whether giving iron and a blood-boosting medicine (EPO) helps patients with bacterial heart valve infections who have low red blood cells. The goal is to see if it speeds recovery and improves how patients feel.
CopenhagenAges 18 years+ - NCT07549880Recruiting
Ultrasound to detect infections after abdominal surgery
This study tests whether bedside ultrasound—a simple imaging tool used at your hospital bed—can help doctors spot surgical infections early after abdominal surgery. Catching infections sooner might help you recover faster and avoid serious complications.
Herlev, Capital RegionAges 18 years+ - NCT07552038Recruiting
Dental Care Management for People Living With HIV
This study looks at how dentists can best care for people with HIV. Researchers will review dental and health records at hospitals in the Pays de la Loire region to understand what works best for keeping teeth and gums healthy when you have HIV.
Nantes, NantesAges 18 years+ - NCT07579312Recruiting
Blood Test for Diagnosing Belly Infections in Kids and Adults
This study tests whether a simple blood test measuring RNA levels can help doctors quickly identify intra-abdominal infections (infections inside the belly) in patients with abdominal pain. If successful, it could help doctors decide faster whether imaging or surgery is needed.
Washington D.C., District of ColumbiaAges 7 years+ - NCT07603128Recruiting
Testing a tool to predict antibiotic-resistant infections in ICU patients
This study validates a prediction tool designed to identify which ICU patients are at risk of developing multidrug-resistant gram-negative bacteria (a serious infection resistant to many antibiotics). The tool may help doctors start appropriate treatment earlier and improve patient outcomes.
Nanjing, JiangsuAges 18 years+ - NCT07610772RecruitingPhase 1
Safety study of a new hepatitis B antibody for hepatitis D
This early-stage trial tests whether a new monoclonal antibody (a lab-made protein that fights viruses) is safe and effective in people with chronic hepatitis D infection. Hepatitis D only occurs in people who also have hepatitis B, and this new treatment may help control the virus.
AarhusAges 18–70 - NCT07633288RecruitingPhase 2
AP1189 Safety and Efficacy for Severe Respiratory Viral Infection
This trial tests whether an experimental drug called AP1189, added to standard hospital care, can help people hospitalized with severe breathing problems from viruses like COVID-19, flu, or RSV. The goal is to see if it reduces the need for mechanical ventilation or other life support.
Mostar, Herzegovina-Neretva CantonAges 18 years+ - NCT07658534RecruitingPhase 2/Phase 3
Ziresovir for high-risk adults with RSV
This trial tests an antiviral drug called Ziresovir in adults with RSV who have health conditions that make them high-risk, such as lung disease, heart disease, or a weakened immune system. It aims to see if the drug can reduce symptoms like coughing and shortness of breath.
Beijing, Beijing MunicipalityAges 18–85 - NCT07619924Enrolling by invitationEarly Phase 1
Phage Cocktail for Hard-to-Treat Skin Infections
This study tests a new treatment called a phage cocktail (viruses that kill bacteria) for skin infections caused by bacteria that don't respond well to regular antibiotics. The treatment is applied directly to the wound to see if it's safe and effective.
Xi'an, ShaanxiAges 18–75 - NCT07355452Enrolling by invitation
Leg closure after heart bypass vein harvesting
This trial compares two ways of closing the leg after doctors remove a vein for heart bypass surgery. The goal is to see which method leads to better healing and fewer complications.
Karachi, SindhAges 18–70 - NCT07322146Enrolling by invitationPhase 4
Shorter antibiotics for children with common infections
This study tests whether shorter courses of antibiotics are as effective as longer ones for children hospitalized with pneumonia, skin infections, or urinary tract infections. It may help children get back to normal faster and reduce side effects.
Birmingham, AlabamaAges 2 months–17 years - NCT07228702Enrolling by invitationPhase 1
Bacteriophage therapy for one patient with lung infection
This is a special program for one patient with a lung infection from Mycobacterium abscessus. The trial uses a treatment with bacteriophages, which are viruses that attack specific bacteria.
Vancouver, British ColumbiaAges Any age - NCT07212764Enrolling by invitation
Tracking infections in kids with FMF using a phone app
This study tests whether a mobile app can help monitor infections in children and teenagers with Familial Mediterranean Fever (FMF). It aims to make it easier for families to track symptoms from home.
Istanbul, FatihAges 8–18 - NCT07108803Enrolling by invitation
Surgery for heart infection study
This study looks at people who have heart surgery to treat a serious heart infection called infective endocarditis. It helps doctors learn more about how these surgeries work and what affects recovery.
Trieste, TRIESTEAges 18 years+ - NCT07070284Enrolling by invitation
Severe pneumonia in older adults: a study of risks and outcomes
This study looks at older adults with severe pneumonia to understand what causes it and how to improve outcomes. If you are 65 or older and have severe pneumonia, this trial may help doctors learn more about your condition.
Zagreb, City of ZagrebAges 65 years+ - NCT07039955Enrolling by invitation
Preventing CPE germ spread in ICU patients
This trial tests whether daily cleansing with a special soap (chlorhexidine) combined with thoughtful use of antibiotics and stomach acid reducers can help prevent the spread of a tough germ called CPE (carbapenemase-producing Enterobacteriaceae) in the ICU. It aims to keep ICU patients safer from infection.
Chuncheon, Gangwon-doAges 19 years+ - NCT07009548Enrolling by invitationPhase 4
CytoGam for CMV in solid organ transplant recipients
This trial tests whether adding CytoGam (an antibody treatment) to standard antiviral therapy can better treat CMV (a common virus) in people who have received a solid organ transplant. It may help those with high virus levels or a new infection after transplant.
Pittsburgh, PennsylvaniaAges 18–75 - NCT06867887Enrolling by invitation
Finding LVAD driveline infections with your smartphone
This trial tests a way to find infections where the LVAD driveline enters your body, using just your smartphone camera. If you have an LVAD, you might be able to join and help researchers see if this simple method works.
RotterdamAges 16–99 - NCT06833125Enrolling by invitationPhase 3
Garlic tablets to prevent infections in ICU patients
This trial tests whether garlic tablets can help prevent hospital-acquired infections in ICU patients. It may be an option for adults in the ICU who do not currently have an infection.
Alexandria, Alexandria GovernorateAges 18–65
Hear when a new Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for infections?
- Yes. Clin2 currently lists 1,767 recruiting infections studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a infections trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a infections trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.